Member Info for Shukan

we are at 6.5p that's the POINT or did this pass you by

Successful fundraising of £11.5m at 10p per share included institutional support from German, Danish, UK and Irish investors and investment from the Greenlandic and Danish Government investment funds

1.1M at 3.8 -happy days sold the rest now hold 2.3% of DKE
Glad to be of help - have a great day

PILEOF DS- GAVE THE KIDS SOME POCKET MONEY

Orgenesis, who signed a commercial death with Hemo in 2018 to develop and sell their HuPHEC cells and mice released market sensitive information late friday early Saturday.

Hemogenyx will have to release an RNS on Monday.

Orgenesis presentation link below. Related to:

. Hemogenyx mice (appear to be commercially ready)

. Hemogenyx mice used for covid treatment identification and testing

. Hemogenyx mice used for covid vaccine identification and testing

. Hemogenyx Hu-PHEC cells being described as Breakthrough in cloning pathogen antibodies for use against virus x!! (the big one)

To note :
No mention in Orgenesis presentation about Hu-PHEC leukaemia treatment, but I'll bet my last pound that if they are confident enough to that Hu-PHEC can help in COVID fight they must have developed confidence while trailing and developing Hemogenyx Hu-PHEC and mice for their original intentions.

In Feb orgenesis made the final £500,000 loan to Hemo to support Hu-PHEC and mice developments. Patents were granted in April and come into force next week. All the blocks are in place..

LOL LOL try harder

Pre emptive RNS strike
https://ir.orgenesis.com/presentations
BOOM as they say

Can we cut the crap on other stocks - ONLY INTERESTED IN HEMOGENYX no flying figs given .

Understand- you have no argument with me going forward just want the company to deliver after a false start since listing - it appears we will have buckets of them shortly , the RNS rightly laid out the road map for shareholders and future shareholders I do believe we are in for a great ride

No need to ramp the company RNS feed tells us all we need to know - I think being three and half years as a large shareholder I have decent insight into the company and know the directors since pre RTO - just hold and ignore the noise

Quickdraw- i have checked and quite rightly you are correct , they are one of the same, i was referring to the original 2014 patent application and the final acceptance 2020.
Dr Vlad has very strong connections in New York and within the Pharma world - works with J&J AI tech at their labs on his research- he does NEED TO PUMP ANYTHING in truth . How he runs his company is his choice and not yours or mine - personally i do not see anything wrong -he is doing an outstanding job this will be come clear.

Back to Hemogenyx- I hope everyone was filling their boots on the sell off over the past week , I had a decent chunk at 5.5 pre market buy averaging up from 3p to 4p , TR1 In place gives us blue skies to the expected RNS followed by the ZAK interview, we haven’t left the station yet-market very bullish into the teens on any company update the companies last RNS was a great marker for what’s to come here join the dots research and relax

SAM with respect nobody is interested in your trades discussion is for HEMO shareholders and those researching

Application/ Approval- his tweets are factual two different dates - do keep up

Yep

After RNS -

U haven’t a clue mate - give up and go home

No

No

1p paid